Hanmi Pharm, Stock Price +2.95% at This Time... Institutional Investors Net Buy 68,371 Shares in Last 5 Days

Hanmi Pharm is trading at 367,000 KRW as of 2:30 PM on the 30th, up 2.95% from the previous day. The trading volume is 275,375 shares, which is 62.72% of the previous day's volume. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.

On November 27, Hyungsoo Kim, a researcher at Cape Investment & Securities, stated, "A research and development-focused pharmaceutical company that has proven its new drug development capabilities through multiple technology exports. Although there is some disappointment due to the termination of technology export contracts, attention should be paid to the new drug development know-how acquired during that period. A global new drug launch is expected in 2021. Profitability has deteriorated due to the reflection of joint development costs with Sanofi, whose contract was terminated. A global new drug launch is expected in 2021." He set Hanmi Pharm's target price at 400,000 KRW.

Over the past five days, individual investors have net sold 61,638 shares of Hanmi Pharm, while foreigners and institutions have net bought 2,273 shares and 68,371 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.